These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3457388)
1. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. Ishihara Y; Uchida Y; Kitamura S Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388 [TBL] [Abstract][Full Text] [Related]
2. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise. Shikano M; Ito T; Ogawa K; Satake T Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562 [TBL] [Abstract][Full Text] [Related]
3. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H Stroke; 1985; 16(2):241-4. PubMed ID: 3883580 [TBL] [Abstract][Full Text] [Related]
4. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord]. Morimoto K; Ikata T; Tounai T Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197 [TBL] [Abstract][Full Text] [Related]
5. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC; Fletcher JR; Zmudka MI; Ramwell PW J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528 [TBL] [Abstract][Full Text] [Related]
6. Effects of thromboxane synthase inhibition on air emboli lung injury in sheep. Fukushima M; Kobayashi T J Appl Physiol (1985); 1986 Jun; 60(6):1828-33. PubMed ID: 3755131 [TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
8. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. Kubo K; Kobayashi T Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941 [TBL] [Abstract][Full Text] [Related]
9. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats. Gomi T; Ikeda T; Ishimitsu T; Uehara Y Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581. Garcia-Szabo R; Kern DF; Malik AB Prostaglandins; 1984 Dec; 28(6):851-66. PubMed ID: 6543018 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581. Mehta J; Mehta P; Ostrowski N Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels]. Baba H Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521 [TBL] [Abstract][Full Text] [Related]
13. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects. Morio H; Hirai A; Terano T; Tamura Y; Yoshida S Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052 [TBL] [Abstract][Full Text] [Related]
14. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Isozaki H; Okajima K; Hara H; Kobayashi M Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815 [TBL] [Abstract][Full Text] [Related]
15. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death. Edmonds LC; Lefer AM Life Sci; 1984 Oct; 35(17):1763-8. PubMed ID: 6434893 [TBL] [Abstract][Full Text] [Related]
16. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs. Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822 [TBL] [Abstract][Full Text] [Related]
17. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase. Davenport NJ; Goldstein RE; Feuerstein GZ J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633 [TBL] [Abstract][Full Text] [Related]
18. OKY-046 inhibits thromboxane synthesis with no effect on brain edema and neurological status in head traumatized rats. Shapira Y; Yadid G; Cotev S; Shohami E Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):49-55. PubMed ID: 2740414 [TBL] [Abstract][Full Text] [Related]
19. Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs. Nagai H; Yakuo I; Togawa M; Arimura A; Matsuura N; Koda A; Hamano S; Ujiie A; Nakazawa M Prostaglandins Leukot Med; 1987 Dec; 30(2-3):111-21. PubMed ID: 2447593 [TBL] [Abstract][Full Text] [Related]
20. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]